{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:48:19Z","timestamp":1792183699008,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of Hunan Provincial Health Commission","award":["D202304019574"],"award-info":[{"award-number":["D202304019574"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01861-2","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:34:09Z","timestamp":1761892449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["miR-3662 targets CAB39L to promote proliferation and invasion in gastric cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"Yong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"1861_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1861_CR2","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1136\/gutjnl-2011-301647","volume":"62","author":"M Kato","year":"2013","unstructured":"Kato M, Nishida T, Yamamoto K, et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut. 2013;62:1425\u201332.","journal-title":"Gut"},{"key":"1861_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4251\/wjgo.v11.i1.28","volume":"11","author":"T Nishida","year":"2019","unstructured":"Nishida T, Sugimoto A, Tomita R, et al. Impact of time from diagnosis to chemotherapy in advanced gastric cancer: a propensity score matching study to balance prognostic factors. World J Gastrointest Oncol. 2019;11:28\u201338.","journal-title":"World J Gastrointest Oncol"},{"key":"1861_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-015-0276-9","volume":"35","author":"W Xu","year":"2016","unstructured":"Xu W, Yang Z, Lu N. Molecular targeted therapy for the treatment of gastric cancer. J Exp Clin Cancer Res. 2016;35:1.","journal-title":"J Exp Clin Cancer Res"},{"key":"1861_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.5414\/CP204250","volume":"60","author":"M Ye","year":"2022","unstructured":"Ye M, Xiu LJ, Ji QQ, et al. Research progress in targeted therapies for gastric cancer. Int J Clin Pharmacol Ther. 2022;60:509\u201314.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"10","key":"1861_CR6","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3390\/jcm12103391","volume":"12","author":"S Ariga","year":"2023","unstructured":"Ariga S. History and future of HER2-targeted therapy for advanced gastric cancer. J Clin Med. 2023;12(10):3391.","journal-title":"J Clin Med"},{"key":"1861_CR7","doi-asserted-by":"publisher","first-page":"1148131","DOI":"10.3389\/fonc.2023.1148131","volume":"13","author":"D Xu","year":"2023","unstructured":"Xu D, Luo Y, Wang P, et al. Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer. Front Oncol. 2023;13:1148131.","journal-title":"Front Oncol"},{"key":"1861_CR8","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.3748\/wjg.v20.i19.5700","volume":"20","author":"HB Hua","year":"2014","unstructured":"Hua HB, Yan TT, Sun QM. miRNA polymorphisms and risk of gastric cancer in Asian population. World J Gastroenterol. 2014;20:5700\u20137.","journal-title":"World J Gastroenterol"},{"key":"1861_CR9","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.7150\/jca.59747","volume":"12","author":"Y Huang","year":"2021","unstructured":"Huang Y, Du X, Chen X, et al. MiR-301a-5p\/SCIN promotes gastric cancer progression via regulating STAT3 and NF-\u03baB signaling. J Cancer. 2021;12:5394\u2013403.","journal-title":"J Cancer"},{"key":"1861_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.gene.2017.09.071","volume":"641","author":"L Li","year":"2018","unstructured":"Li L, Zhao J, Huang S, et al. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the hippo signaling pathway. Gene. 2018;641:240\u20137.","journal-title":"Gene"},{"key":"1861_CR11","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12411","author":"W Wei","year":"2021","unstructured":"Wei W, Liu C, Yao R, et al. MiR-486-5p suppresses gastric cancer cell growth and migration through downregulation of fibroblast growth factor 9. Mol Med Rep. 2021. https:\/\/doi.org\/10.3892\/mmr.2021.12411.","journal-title":"Mol Med Rep"},{"key":"1861_CR12","doi-asserted-by":"publisher","first-page":"1181628","DOI":"10.3389\/fcell.2023.1181628","volume":"11","author":"P Jiang","year":"2023","unstructured":"Jiang P, Liang B, Zhang Z, et al. Microrna-146a-5p induces cell cycle arrest and enhances apoptosis in gastric cancer via targeting CDC14A. Front Cell Dev Biol. 2023;11:1181628.","journal-title":"Front Cell Dev Biol"},{"key":"1861_CR13","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/2211-5463.13125","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang J, Zhang M, Hu X, et al. MiRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1. FEBS Open Bio. 2021;11:1814\u201326.","journal-title":"FEBS Open Bio"},{"key":"1861_CR14","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1038\/s41598-020-61633-8","volume":"10","author":"X Yang","year":"2020","unstructured":"Yang X, Zhang Z. Microrna hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma. Sci Rep. 2020;10:4672.","journal-title":"Sci Rep"},{"key":"1861_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.4103\/jcrt.jcrt_280_21","volume":"17","author":"S Li","year":"2021","unstructured":"Li S, Zhang M, Xu F, Wang Y, Leng D. Detection significance of miR-3662, miR-146a, and miR-1290 in serum exosomes of breast cancer patients. J Cancer Res Ther. 2021;17:749\u201355.","journal-title":"J Cancer Res Ther"},{"key":"1861_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14488","volume":"103","author":"X Li","year":"2024","unstructured":"Li X, Chu X, Wang H, Xiang L, Yue X. Serum exosomal miR-3662 down- regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells. Chem Biol Drug Des. 2024;103:e14488.","journal-title":"Chem Biol Drug Des"},{"key":"1861_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41419-018-0616-8","volume":"9","author":"Z Chen","year":"2018","unstructured":"Chen Z, Zuo X, Zhang Y, et al. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1\u03b1-mediated Warburg effect. Cell Death Dis. 2018;9:549.","journal-title":"Cell Death Dis"},{"key":"1861_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4149\/neo_2020_190730N689","volume":"67","author":"J Ye","year":"2020","unstructured":"Ye J, Xiao X, Han Y, et al. MiR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells. Neoplasma. 2020;67:773\u201381.","journal-title":"Neoplasma"},{"key":"1861_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.545460","volume":"10","author":"Z Wang","year":"2020","unstructured":"Wang Z, Deng M, Chen L, et al. Circular RNA circ-03955 promotes epithelial- mesenchymal transition in osteosarcoma by regulating miR-3662\/metadherin pathway. Front Oncol. 2020;10:545460.","journal-title":"Front Oncol"},{"key":"1861_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114146","volume":"43","author":"S Lee","year":"2024","unstructured":"Lee S, Bondaruk J, Wang Y, et al. Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis. Cell Rep. 2024;43:114146.","journal-title":"Cell Rep"},{"key":"1861_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040716","author":"Y Wu","year":"2023","unstructured":"Wu Y, Xu Z, Chen X, Fu G. Bioinformatics prediction and experimental verification identify CAB39L as a diagnostic and prognostic biomarker of kidney renal clear cell carcinoma. Medicina (Kaunas). 2023. https:\/\/doi.org\/10.3390\/medicina59040716.","journal-title":"Medicina (Kaunas)"},{"key":"1861_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12253-015-9973-0","volume":"22","author":"MR Choi","year":"2016","unstructured":"Choi MR, An CH, Yoo NJ, Lee SH. Frameshift mutations of CAB39L, an activator of LKB1 tumor suppressor, in gastric and colorectal cancers. Pathol Oncol Res. 2016;22:225\u20136.","journal-title":"Pathol Oncol Res"},{"key":"1861_CR23","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1038\/s41388-018-0402-1","volume":"37","author":"W Li","year":"2018","unstructured":"Li W, Wong CC, Zhang X, et al. CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1\u03b1 axis to inhibit gastric tumorigenesis. Oncogene. 2018;37:6383\u201398.","journal-title":"Oncogene"},{"key":"1861_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/07357907.2018.1477955","volume":"36","author":"IG Motofei","year":"2018","unstructured":"Motofei IG. Biology of cancer; from cellular cancerogenesis to supracellular evolution of malignant phenotype. Cancer Invest. 2018;36:309\u201317.","journal-title":"Cancer Invest"},{"key":"1861_CR25","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10620-017-4506-1","volume":"62","author":"BC Richard","year":"2017","unstructured":"Richard BC. Non-coding RNA: It\u2019s Not Junk. Dig Dis Sci. 2017;62:1107\u20139.","journal-title":"Dig Dis Sci"},{"key":"1861_CR26","doi-asserted-by":"publisher","first-page":"D149","DOI":"10.1093\/nar\/gkm995","volume":"36","author":"D Betel","year":"2008","unstructured":"Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008;36:D149-153.","journal-title":"Nucleic Acids Res"},{"key":"1861_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s12094-021-02599-5","volume":"23","author":"A Liu","year":"2021","unstructured":"Liu A, Xu J. Circ_03955 promotes pancreatic cancer tumorigenesis and warburg effect by targeting the miR-3662\/HIF-1\u03b1 axis. Clin Transl Oncol. 2021;23:1905\u201314.","journal-title":"Clin Transl Oncol"},{"key":"1861_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00280-021-04289-z","volume":"88","author":"A Liu","year":"2021","unstructured":"Liu A, Zhou Y, Zhao T, et al. Mirna-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism. Cancer Chemother Pharmacol. 2021;88:343\u201357.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1861_CR29","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.2147\/CMAR.S200540","volume":"11","author":"L Zhu","year":"2019","unstructured":"Zhu L, Liu Z, Dong R, et al. Microrna-3662 targets ZEB1 and attenuates the invasion of the highly aggressive melanoma cell line A375. Cancer Manag Res. 2019;11:5845\u201356.","journal-title":"Cancer Manag Res"},{"key":"1861_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.trsl.2015.05.009","volume":"166","author":"T Powr\u00f3zek","year":"2015","unstructured":"Powr\u00f3zek T, Krawczyk P, Kowalski DM, et al. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers. Transl Res. 2015;166:315\u201323.","journal-title":"Transl Res"},{"key":"1861_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41388-021-02089-6","volume":"41","author":"B Yi","year":"2022","unstructured":"Yi B, Wang S, Wang X, et al. CRISPR interference and activation of the microRNA-3662-HBP1 axis control progression of triple-negative breast cancer. Oncogene. 2022;41:268\u201379.","journal-title":"Oncogene"},{"key":"1861_CR32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/genes10110879","volume":"10","author":"JL Berry","year":"2019","unstructured":"Berry JL, Polski A. The RB1 story: characterization and cloning of the first tumor suppressor gene. Genes (Basel). 2019;10:879.","journal-title":"Genes (Basel)"},{"key":"1861_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-015-0048-3","volume":"4","author":"S Heerboth","year":"2015","unstructured":"Heerboth S, Housman G, Leary M, et al. EMT and tumor metastasis. Clin Transl Med. 2015;4:6.","journal-title":"Clin Transl Med"},{"key":"1861_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.06.034","volume":"11","author":"Z Xu","year":"2024","unstructured":"Xu Z, Davies ER, Yao L, et al. LKB1 depletion-mediated epithelial- mesenchymal transition induces fibroblast activation in lung fibrosis. Genes Dis. 2024;11:101065.","journal-title":"Genes Dis"},{"key":"1861_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11010-015-2592-y","volume":"411","author":"Y Wu","year":"2016","unstructured":"Wu Y, Qi Y, Liu H, et al. AMPK activator AICAR promotes 5-FU-induced apoptosis in gastric cancer cells. Mol Cell Biochem. 2016;411:299\u2013305.","journal-title":"Mol Cell Biochem"},{"key":"1861_CR36","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s10528-020-10022-x","volume":"59","author":"XL Hu","year":"2021","unstructured":"Hu XL, Zhu YJ, Hu CH, et al. Ghrelin affects gastric cancer progression by activating AMPK signaling pathway. Biochem Genet. 2021;59:652\u201367.","journal-title":"Biochem Genet"},{"key":"1861_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s13402-020-00508-6","volume":"43","author":"J Shen","year":"2020","unstructured":"Shen J, Jin Z, Lv H, et al. PFKP is highly expressed in lung cancer and regulates glucose metabolism. Cell Oncol (Dordr). 2020;43:617\u201329.","journal-title":"Cell Oncol (Dordr)"},{"key":"1861_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12935-023-03162-8","volume":"23","author":"H Yang","year":"2023","unstructured":"Yang H, Yang S, He J, et al. Glucose transporter 3 (GLUT3) promotes lactylation modifications by regulating lactate dehydrogenase A (LDHA) in gastric cancer. Cancer Cell Int. 2023;23:303.","journal-title":"Cancer Cell Int"},{"key":"1861_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/path.5852","volume":"256","author":"I Saltarella","year":"2022","unstructured":"Saltarella I, Lamanuzzi A, Desantis V, et al. Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs. J Pathol. 2022;256:402\u201313.","journal-title":"J Pathol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01861-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:51:02Z","timestamp":1764917462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01861-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01861-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have consent to publish the paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}],"article-number":"344"}}